CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 136 filers reported holding CASTLE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,833,000 | -13.7% | 147,867 | -4.9% | 0.38% | -1.8% |
| Q2 2021 | $11,398,000 | +1.8% | 155,437 | -5.0% | 0.38% | -5.0% |
| Q1 2021 | $11,201,000 | +12.6% | 163,607 | +10.4% | 0.40% | +8.3% |
| Q4 2020 | $9,951,000 | +17.2% | 148,197 | -10.2% | 0.37% | +11.7% |
| Q3 2020 | $8,494,000 | +52.6% | 165,098 | +11.8% | 0.33% | +37.6% |
| Q2 2020 | $5,568,000 | – | 147,725 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |